Position in KRYS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$22,759,584
+$5,168,251 QoQ
Shares Held
61,236
-10.1% QoQ
Ownership
0.207%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#49
of 419 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 51%
Shared 0%
None 49%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. KRYS ranks #16 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in KRYS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,759,584 | 61,236 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $17,591,333 | 68,099 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $16,379,131 | 66,436 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $12,454,544 | 70,552 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $9,725,707 | 70,753 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $12,391,478 | 68,727 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $10,830,845 | 69,136 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $12,798,347 | 70,309 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $13,164,233 | 71,685 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $5,711,375 | 32,099 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,943,247 | 31,785 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $3,758,748 | 32,403 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $3,641,161 | 31,015 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $2,599,468 | 32,469 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,521,889 | 31,834 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,169,273 | 31,123 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,870,325 | 28,485 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,586,247 | 23,839 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,515,606 | 21,667 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,124,812 | 21,544 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,406,512 | 20,684 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $1,155,522 | 14,999 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $906,600 | 15,110 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $588,708 | 13,675 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $629,376 | 15,195 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $526,447 | 12,175 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||